Specialty & fine chemicals
Probiotic oral care
The ecological plaque hypothesis, how Streptococcus mutans acidifies and anchors biofilm, what bacteriocin-producing S. salivarius strains are proposed to do, and why timing of the dose matters.
Probiotic oral care delivers named bacterial strains — usually in a lozenge — on the premise that the mouth’s problems are ecological rather than simply hygienic.
Why the ecological framing matters
Dental plaque is a biofilm present in every healthy mouth. Caries does not begin when bacteria arrive; it begins when the balance within that biofilm shifts.
The ecological plaque hypothesis describes the shift. Frequent fermentable sugar gives acid-producing bacteria a substrate; the resulting drop in plaque pH is tolerated by Streptococcus mutans and lactobacilli but not by most commensal streptococci, so the acid-tolerant organisms gain proportion, which lowers pH further. It is a positive feedback loop, and it runs on frequency of sugar exposure more than total quantity — each exposure resets the clock on the pH recovery that saliva provides.
S. mutans is the classic driver for two linked reasons. It is acidogenic and aciduric — it makes acid and survives it — and its glucosyltransferases convert sucrose into insoluble glucans that physically anchor the biofilm to enamel and shelter it from salivary buffering. Demineralisation begins around pH 5.5, the point at which enamel hydroxyapatite is no longer in equilibrium with the surrounding fluid.
Gingivitis and halitosis follow a different but analogous shift, toward Gram-negative anaerobes producing volatile sulfur compounds — hydrogen sulfide and methyl mercaptan — from sulfur-containing amino acids, mostly on the posterior tongue.
What the strains are proposed to do
The commercially defined strains are Streptococcus salivarius K12 and M18. S. salivarius is a natural early coloniser of the oral mucosa and tongue, which is the first argument in their favour: they are being returned to a niche they belong in.
Their proposed mechanism is bacteriocin production — salivaricins, ribosomally synthesised peptides that inhibit closely related species. Narrow spectrum is the point: unlike an antiseptic mouthwash, a bacteriocin targets relatives of the producer rather than clearing the community wholesale. M18 is additionally described as producing dextranase and urease, which would act on the glucan matrix and on plaque acidity respectively.
Where the limits are
Colonisation is transient and dose-dependent. These strains are generally cleared once dosing stops, so the effect, if real, requires continued use — this is closer to a maintenance regimen than a cure.
The niche must be open. The usual instruction to take the lozenge after brushing at night reflects a real constraint: an established biofilm resists a newcomer, so the dose is timed to the moment of lowest competition and lowest salivary clearance.
Sucrose still drives the system. No strain removes the substrate. A probiotic acting against an unchanged sugar-frequency pattern is working against the feedback loop rather than interrupting it.
Trial evidence is strongest for halitosis, where the endpoint is a measurable volatile sulfur compound reading, and weaker and shorter for caries, whose endpoint takes years to develop.